The FDA Releases a New Webpage During Covid-19 Outbreak

The U.S. Food and Drug Administration (FDA) released a new webpage of information to help address questions patients and caregivers may have about FDA-regulated medical products (drugs, biologics, and devices) during the coronavirus (COVID-19) outbreak. The webpage is a source of information for patients during this time of crisis. Visitors to the page can find information on:

  • FDA COVID-19 resources, such as questions and answers on hand sanitizers;
  • How patients can report a drug, biologic, or medical device product shortage; and
  • Information on clinical trials and the FDA’s Expanded Access program.

 

Please visit the webpage at https://www.fda.gov/patients/coronavirus-disease-2019-covid-19-resources-patients. For additional questions you may have, please contact the FDA’s Patient Affairs Staff at 301-796-8460 or email patientaffairs@fda.hhs.gov.

Other Patient Resources:

For Patients
https://www.fda.gov/patients

 

Questions and Answers for Patients About Clinical Trials During COVID-19 Outbreak

https://www.fda.gov/patients/coronavirus-disease-2019-covid-19-resources-patients/questions-and-answers-patients-about-clinical-trials-during-covid-19-outbreak

 

Patient Affairs Staff (PAS)
Office of the Commissioner
U.S. Food and Drug Administration

Tel: 301-796-8460
Email: PatientAffairs@fda.gov

 

Want to learn more about how PAS works to improve, expand and maintain communication with patients, check out the Patient Affairs Staff webpage, email us at PatientAffairs@fda.gov or follow us on Twitter @FDAPatientInfo.

Should you wish to opt-out of future communications from the Patient Affairs Staff, please send an email to PatientAffairs@fda.gov.